MicroGenDX Blog

Urinary tract infections (UTIs) are a common ailment affecting millions of individuals every year. While antibiotics have long been a cornerstone of UTI treatment, the rise of antibiotic resistance is a concerning issue in modern healthcare. Empiric antibiotic therapy, which is prescribed in absence of knowing what pathogens are present, is a standard approach to UTI treatment. However, the effectiveness of empiric antibiotics is dwindling due to rising antibiotic resistance. In this blog, we'll delve into the growing concern of antibiotic resistance, focusing on cephalosporins, potentiated sulfonamides and fluoroquinolones, three of the most commonly used antibiotic classes, and share insights […]

In the dynamic field of urology, the advent of Next-Generation DNA Sequencing (NGS) has ushered in a new era of diagnostic precision and therapeutic insight. NGS technology has paved the way for innovative approaches to understanding and managing infectious diseases within the realm of urology. In this blog, we will explore how NGS is transforming the landscape of urinary tract infections (UTIs) and shedding light on the urinary microbiome. Unraveling the Complexity of Urinary Tract Infections UTIs are among the most common infectious diseases in urology, affecting millions of individuals worldwide. Traditionally, diagnosing UTIs has relied on culture-based techniques, which […]

In the world of medicine, antibiotic resistance is a growing concern that poses a serious threat to public health. Empiric antibiotic therapy, which involves selecting antibiotics based on clinical symptoms and local resistance patterns, has been the standard approach for treating infections. However, the rise of antibiotic-resistant pathogens demands a more precise and effective strategy. Next-Generation DNA Sequencing (NGS) is emerging as a game-changer in this regard, allowing medical professionals to tailor antibiotic therapy to the specific infectious agents detectable by DNA profiling. In this blog post, we will explore how NGS technology is revolutionizing the selection of first-line antibiotics.  […]